TruBridge projects modest 2026 revenue growth while targeting significant margin expansion. The healthcare IT company expects to improve adjusted EBITDA margins by 200 basis points, signaling operational efficiency gains ahead. CEO Christopher Fowler highlighted that the company completed its 10-K filing after addressing certain out-of-period adjustments identified during audit procedures with its new external auditor. The strategic review underway suggests management is evaluating potential operational improvements and cost optimization initiatives. Investors should monitor upcoming quarterly results to assess whether the company can execute on its margin improvement targets while maintaining revenue momentum in a competitive healthcare technology market.
Post from MarketNews_en
Log in to interact with content.